Should You Buy Bitcoin in 2024? [Expert's Shocking Answer]

Bitcoin minted 100,000 millionaires and if you're not one of them, that ship has sailed. But there's another millionaire-minting crypto at our doorstep... research shows this coin could be 20X bigger than Bitcoin by the end of the decade. With crypto starting to heat up again, this could be the perfect time to get in.

South Africa, Colombia and others are fighting drugmakers over access to TB and HIV drugs

GERALD IMRAY and MARIA CHENG
November 24, 2023

CAPE TOWN, South Africa (AP) -- South Africa, Colombia and other countries that lost out in the global race for coronavirus vaccines are taking a more combative approach towards drugmakers and pushing back on policies that deny cheap treatment to millions of people with tuberculosis and HIV.

Experts see it as a shift in how such countries deal with pharmaceutical behemoths and say it could trigger more efforts to make lifesaving medicines more widely available.

In the COVID-19 pandemic, rich countries bought most of the world's vaccines early, leaving few shots for poor countries and creating a disparity the World Health Organization called "a catastrophic moral failure."

Now, poorer countries are trying to become more self-reliant "because they've realized after COVID they can't count on anyone else," said Brook Baker, who studies treatment-access issues at Northeastern University.

One of the targets is a drug, bedaquiline, that is used for treating people with drug-resistant versions of tuberculosis. The pills are especially important for South Africa, where TB killed more than 50,000 people in 2021, making it the country's leading cause of death.

In recent months, activists have protested efforts by Johnson & Johnson to protect its patent on the drug. In March, TB patients petitioned the Indian government, calling for cheaper generics; the government ultimately agreed J&J's patent could be broken. Belarus and Ukraine then wrote to J&J, also asking it to drop its patents, but with little response.

In July, J&J's patent on the drug expired in South Africa, but the company had it extended until 2027, enraging activists who accused it of profiteering.

The South African government then began investigating the company's pricing policies. It had been paying about 5,400 rand ($282) per treatment course, more than twice as much as poor countries that got the drug via a global effort called the Stop TB partnership.

In September, about a week after South Africa's probe began, J&J announced that it would drop its patent in more than 130 countries, allowing generic-makers to copy the drug.

"This addresses any misconception that access to our medicines is limited," the company said.

Christophe Perrin, a TB expert at Doctors Without Borders, called J&J's reversal "a big surprise" because aggressive patent protection was typically a "cornerstone" of pharmaceutical companies' strategy.

Meanwhile, in Colombia, the government declared last month that it would issue a compulsory license for the HIV drug dolutegravir without permission from the drug's patent-holder, Viiv Healthcare. The decision came after more than 120 groups asked the Colombian government to expand access to the WHO-recommended drug.

"This is Colombia taking the reins after the extreme inequity of COVID and challenging a major pharmaceutical to ensure affordable AIDS treatment for its people," said Peter Maybarduk of the Washington advocacy group Public Citizen. He noted that Brazilian activists are pushing their government to make a similar move.

Still, some experts said much more needs to change before poorer countries can produce their own medicines and vaccines.

When the coronavirus pandemic hit, Africa produced fewer than 1% of all vaccines made globally but used more than half of the world's supply, according to Petro Terblanche, managing director of Afrigen Biologics. The company is part of a WHO-backed effort to produce a COVID vaccine using the same mRNA technology as those made by Pfizer and Moderna.

Terblanche estimated about 14 million people died of AIDS in Africa in the late 1990s-2000s, when countries couldn't get the necessary medicines.

Back then, President Nelson Mandela's government in South Africa eventually suspended patents to allow wider access to AIDS drugs. That prompted more than 30 drugmakers to take it to court in 1998, in a case dubbed "Mandela vs. Big Pharma."

Doctors Without Borders described the episode as "a public relations disaster" for the drug companies, which dropped the lawsuit in 2001.

Terblanche said that Africa's past experience during the HIV epidemic has proven instructive.

"It's not acceptable for a listed company to hold intellectual property that stands in the way of saving lives and so, we will see more countries fighting back," she said.

Challenging pharmaceutical companies is just one piece to ensuring Africa has equal access to treatments and vaccines, Terblanche said. More robust health systems are critical.

"If we can't get (vaccines and medicines) to the people who need them, they aren't useful," she said.

Yet some experts pointed out that South Africa's own intellectual property laws still haven't been changed sufficiently and make it too easy for pharmaceutical companies to acquire patents and extend their monopolies.

While many other developing countries allow legal challenges to a patent or a patent extension, South Africa has no clear law that allows it to do that, said Lynette Keneilwe Mabote-Eyde, a health care activist who consults for the nonprofit Treatment Action Group.

The South African department of health didn't respond to a request for comment regarding drug procurement and patents.

Andy Gray, who advises the South African government on essential medicines, said J&J's recent decision to not enforce its patent may have more to do with the drug's limited future earnings than caving to pressure from activists.

"Because bedaquiline is not ever going to sell in huge volumes in high-income countries, it's the sort of product they would love to offload at some stage and perhaps earn a royalty from," said Gray, a senior lecturer in pharmacology at the University of KwaZulu-Natal.

In its annual report on TB released earlier this month, the World Health Organization said there were more than 10 million people sickened by the disease last year and 1.3 million deaths. After COVID-19, tuberculosis is the world's deadliest infectious disease and it is now the top killer of people with HIV. WHO noted only about 2 in 5 people with drug-resistant TB are being treated.

Zolelwa Sifumba, a South African doctor, was diagnosed with drug-resistant TB in 2012 when she was a medical student and endured 18 months of treatment taking about 20 pills every day in addition to daily injections, which left her in "immense pain" and resulted in some hearing loss. Bedaquiline was not rolled out as a standard treatment in South Africa until 2018.

"I wanted to quit (treatment) every single day," she said. Since her recovery, Sifumba has become an advocate for better TB treatment, saying it makes little sense to charge poor countries high prices for essential medicines.

"TB is everywhere but the burden of it is in your lower and middle income countries," she said. "If the lower income countries can't get it (the drug), then what's the point? Who are you making it for?"

___

Cheng reported from London.

___

AP health coverage: https://apnews.com/health

Continue Reading...

Popular

Why Bitcoin Cash And Ethereum Classic Are Falling

Bitcoin Cash (CRYPTO: BCH) and Ethereum Classic (CRYPTO: ETC) are trading lower by 3.5% to $308.14 and 4.7% to $29.72 Thursday afternoon.

Some doorbell cameras sold on Amazon and other online sites have major security flaws, report says

NEW YORK (AP) — Some doorbell cameras sold by Amazon and other online retailers have security flaws that could allow bad actors to view footage from the devices or control them completely, according to an investigation published Thursday by Consumer Reports.

Did This Crypto Millionaire Humiliate Himself? - Ad

On September 2022, crypto millionaire James Altucher published a video saying he had sold all his Bitcoin... and doubled down on this crypto instead. At the time, cryptos had already dropped 70%. But James still said this crypto was a good investment. Was he right? Or did he embarrass himself?

Celsius Holdings CEO Sees 'Huge Runway Ahead' As Stock Soars To New Highs

Celsius shares are soaring to all-time highs Thursday following the company's quarterly results. Celsius CEO John Fieldly still sees plenty of runway ahead for the energy drink maker.

Why Banks Could See a "Cash Frenzy" on March 11 - Ad

He called the Lehman Brothers collapse in 2008... the Bitcoin crash in 2018... and the inflation crisis of 2022. Now, he's warning that the 2023 banking crisis is not over yet. Instead, we could see a cash frenzy at banks as soon as March 11. Do NOT buy another stock until you see his newest presentation.

Stericycle Analysts Increase Their Forecasts After Q4 Results

Stericycle, Inc. (NASDAQ: SRCL) reported mixed fourth-quarter financial results on Wednesday.

The jobs market is hot, but layoffs keep coming in a shifting economic environment

The U.S. economy is humming and there are hundreds of thousands of jobs being added every month. In a stunning burst of hiring to start the year, the nation added 353,000 jobs in January....

The Next Great Crypto Bull Market Has Begun... - Ad

The last of three historically bullish crypto events is expected to happen around April 14. It's only the fourth time in crypto history. The last time, in 2020, certain altcoins exploded. Some as high as 531,735% or even a 953,018% gain. A tiny $100 investment would have returned just short of a million dollars.

A large US health care tech company was hacked. It's leading to billing delays and security concerns

Health care providers across the country are reeling from a cyberattack on a massive U.S. health care technology company that has threatened the security of patients’ information and is delaying some prescriptions and paychecks for medical workers.

Average long-term US mortgage rises to 6.94% after marking fourth-straight weekly increase

LOS ANGELES (AP) — The average long-term U.S. mortgage rate rose for the fourth consecutive week, another setback for prospective homebuyers just as the spring homebuying season gets going.

Digital Dollar: Freedom or Financial Slavery? - Ad

Is a digital dollar really America's way to financial freedom? Or is it the start of a wave of financial servitude? Get the details on the potential risks of a digital dollar and what you can do to protect yourself. From privacy concerns to economic control, protect yourself with this free guide.

New Trump Bombshell - Ad

The Freeport Society and Louis Navellier have just issued a shocking election prediction for 2024. I believe Donald J. Trump will go down as America's last Republican president. But NOT for the reasons you may think...

Will the Reddit IPO Turn Into the Next Meme Stock?

Reddit IPO is around the corner. Here are a few reasons why we think this could turn into the biggest meme stock around.

Conservatives Reveal Two Preferred Candidates For Donald Trump's Running Mate At CPAC

At the 2024 Conservative Political Action Conference (CPAC) on Saturday, attendees showed equal interest in two particular vice presidential candidates for former President Donald Trump as he gears up for the p

Free Report: IRS Loophole Saves US Retirees - Ad

As tax season approaches, many Americans preparing for retirement are nervous about Biden's proposed tax reforms that are targeting high worth individuals. But this IRS Loophole Report offers safety and potentially even opportunity to grow your nest egg.

This Analyst With 87% Accuracy Rate Sees More Than 14% Upside In Nvidia - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts

U.S. stocks closed mixed on Friday, while the Dow Jones index gaining more than 50 points during the session. All three major indices recorded gains last week, with the S&P 500 gaining around 1.7% and the Dow adding 1.3% for the week.

Gold Explodes Past $2,000, Here's What's Next - Ad

After what feels like nearly a decade of disappointing returns, gold is entering a new bull market. You can get started today for just $5.

Top 4 Financial Stocks Which Could Rescue Your Portfolio This Quarter

The most oversold stocks in the financial sector presents an opportunity to buy into undervalued companies.

Elon Musk Buys A New Windows PC, Fears Signing In Will Give Microsoft AI Access To His Computer: 'This Is Messed Up'

Over the weekend, Tesla and SpaceX CEO Elon Musk alleged that Microsoft Corporation (NASDAQ:MSFT) is forcing him to create an account for using his new laptop. 

Inflation Proof Investments - Ad

Forget stocks. Their value goes down even as price goes up. And real estate... not in this market. The #1 inflation proof investment right now is GOLD. If you want to protect your retirement savings from inflation, this free guide from the #1 rated gold company in the US shows you how.

$1000 Invested In Netflix 15 Years Ago Would Be Worth This Much Today

Netflix (NASDAQ:NFLX) has outperformed the market over the past 15 years by 22.96% on an annualized basis producing an average annual return of 37.07%.

Act by April 14 - Ad

The last of three historically bullish crypto events is expected to happen around April 14. It's only the fourth time in crypto history. The last time, in 2020, certain altcoins exploded. Some as high as 531,735% or even a 953,018% gain. A tiny $100 investment would have returned just short of a million dollars.

Big-Time Bitcoin Bull Michael Saylor Encourages Followers To Keep Stacking Coins But 'Stay Humble'

Michael Saylor, CEO of MicroStrategy Inc. (NASDAQ:MSTR), posted a message on X, formerly Twitter, on Wednesday, encouraging Bitcoin (CRYPTO: BTC) holders to “Stay Humble. Stack Sats.”

A collection of the insights Warren Buffett offered in his annual letter Saturday

Billionaire Warren Buffett is known as one of the world's greatest investors, and the 93-year-old has a devout following of people who admire his track record and appreciate his sage advice on life and investing.

URGENT: Do THIS To Avoid Biden's $4.7 Trillion Tax Increase - Ad

Did you know that Joe Biden and his administration proposed a $4.7 trillion tax hike for this year? But a little-known IRS Loophole can keep your money safe. Get the report now before Biden's tax hike can come after your savings.

Amazon, Royal Caribbean Cruises And 2 Other Stocks Insiders Are Selling

The Nasdaq 100 closed higher by around 0.2% on Thursday. Investors, meanwhile, focused on some notable insider trades.

NYC’s plan to ease gridlock and pump billions into mass transit? A $15 toll for Manhattan drivers

NEW YORK (AP) — Between bridge and tunnel tolls, parking fees and the ever-present risk of getting a traffic ticket, it can already cost a mint to drive into Manhattan.

Oil = Monthly Income - Ad

Right now, there's an unusual $25 way to collect MONTHLY income from the oil markets. It's not a stock, bond, or anything you've likely heard about... But it's by far my #1 investment opportunity for 2024.

UK PM Backs Plan To Divert Billions From Frozen Russian Assets To Aid Ukraine: 'We Must Be Bolder With Our Military Support'

UK Prime Minister Rishi Sunak has voiced his support for the proposal to send billions of pounds in interest from frozen Russian assets to Ukraine. This announcement was made during the commemoration of the second anniversary of the Russian invasion of Ukraine.

Fundrise CEO Predicts Coastal Real Estate Markets Are Going To Start Declining

The real estate market is expected to undergo rampant changes as the macroeconomic and geological factors pile on. One of the most significant changes is the declining demand for coastal real estate as the climate change concerns amp up.

Don't Buy NVDA Without Seeing This - Ad

Are you holding America's 2nd most popular stock? It could hurt your portfolio.

Trump Goes After 'Crooked' Judge And 'Totally Corrupt' Attorney General After $355M Fine And 3-Year Ban In New York Civil Fraud Ruling: 'Witch Hunt'

Donald Trump criticizes a New York State judge's ruling imposing a $355 million fine and a three-year ban on company leadership, labeling it as "unAmerican" and part of a broader "witch hunt" against him.

Jim Cramer Tells Investors To 'Do The Homework' And Look Beyond Earnings Figures: '...Causing People To Make Snap Judgments'

CNBC's Jim Cramer has advised investors to look beyond the numbers in financial reports, saying that the current method of reporting is leading to false judgments.

Turn Market Chaos Into Your No. 1 Advantage - Ad

Don't let market volatility erode your hard-earned savings. Our free gold guide shows you how to turn your 401k into a gold IRA and protect your retirement today.

Porch Group And 2 Other Stocks Under $3 Insiders Are Buying

The Dow Jones index closed lower by more than 50 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service